|11.97||-0.79 / -6.19%|
As of 3:59pm ET
|11.97||-0.0024 / -0.02%|
The 5 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 26.00, with a high estimate of 33.00 and a low estimate of 20.00. The median estimate represents a +117.21% increase from the last price of 11.97.
The current consensus among 5 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.